MARZO, TIZIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.858
EU - Europa 2.938
AS - Asia 1.658
SA - Sud America 290
Continente sconosciuto - Info sul continente non disponibili 122
AF - Africa 45
OC - Oceania 19
Totale 10.930
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.779
RU - Federazione Russa 901
IT - Italia 671
PL - Polonia 522
SG - Singapore 449
CN - Cina 365
HK - Hong Kong 262
IE - Irlanda 231
BR - Brasile 225
VN - Vietnam 218
SE - Svezia 127
KR - Corea 117
FI - Finlandia 101
NL - Olanda 78
GB - Regno Unito 76
DE - Germania 74
FR - Francia 66
IN - India 59
CA - Canada 46
JO - Giordania 43
ID - Indonesia 31
AR - Argentina 25
JP - Giappone 21
BD - Bangladesh 20
UA - Ucraina 20
AU - Australia 19
ES - Italia 19
TR - Turchia 16
MX - Messico 15
BE - Belgio 13
CH - Svizzera 13
ZA - Sudafrica 11
CO - Colombia 10
EC - Ecuador 10
IQ - Iraq 10
CI - Costa d'Avorio 9
NG - Nigeria 8
UZ - Uzbekistan 6
VE - Venezuela 6
AT - Austria 5
BG - Bulgaria 5
MA - Marocco 5
PE - Perù 5
PH - Filippine 5
PK - Pakistan 5
AZ - Azerbaigian 4
CL - Cile 4
NI - Nicaragua 4
SA - Arabia Saudita 4
TN - Tunisia 4
XK - ???statistics.table.value.countryCode.XK??? 4
BB - Barbados 3
IL - Israele 3
JM - Giamaica 3
PY - Paraguay 3
RO - Romania 3
AL - Albania 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
MY - Malesia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
BW - Botswana 1
BY - Bielorussia 1
EG - Egitto 1
EU - Europa 1
GT - Guatemala 1
HU - Ungheria 1
IR - Iran 1
KH - Cambogia 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
MQ - Martinica 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
VG - Isole Vergini Britanniche 1
VI - Stati Uniti Isole Vergini 1
Totale 10.813
Salva come PNG Salva come JPEG
Città #
Santa Clara 999
Ashburn 652
Warsaw 521
Fairfield 506
Singapore 315
Chandler 251
Woodbridge 245
Dublin 231
Seattle 215
Hong Kong 212
Houston 195
Cambridge 182
San Jose 178
Wilmington 157
Ann Arbor 120
Seoul 116
Beijing 112
Florence 110
Milan 109
Council Bluffs 105
Lawrence 89
Altamura 87
New York 73
Amsterdam 70
Princeton 69
Ho Chi Minh City 66
Los Angeles 63
Buffalo 53
Hanoi 52
Moscow 52
Boston 47
Rome 45
The Dalles 45
Chicago 43
Lauterbourg 43
Helsinki 42
Munich 40
Clifton 39
Mumbai 32
Turku 32
Dallas 28
Shanghai 25
Medford 24
Jakarta 19
Melbourne 19
San Diego 18
Boardman 16
Hefei 16
London 16
Tokyo 16
Naples 14
Toronto 14
Brussels 13
São Paulo 13
Orem 12
Washington 12
Barcelona 11
Phoenix 11
Redondo Beach 11
Bern 10
Brooklyn 10
Haiphong 10
Kent 10
Miano 10
Paris 10
Abidjan 9
Dong Ket 9
Jacksonville 9
Rio de Janeiro 9
Abuja 8
Da Nang 8
Denver 8
Figino 8
Serra 8
Atlanta 7
Cagliari 7
Falls Church 7
Genoa 7
Las Vegas 7
Manchester 7
Norwalk 7
Tianjin 7
Yubileyny 7
Abbeville 6
Baghdad 6
Charlotte 6
Frankfurt am Main 6
Montreal 6
Padua 6
Porto Alegre 6
San Francisco 6
Stockholm 6
Tashkent 6
Turin 6
Biên Hòa 5
Bologna 5
Chennai 5
Hillsboro 5
Johannesburg 5
Lappeenranta 5
Totale 7.216
Salva come PNG Salva come JPEG
Nome #
The leading established metal-based drugs: a revisitation of their relevant physico-chemical data 672
FROM CONVENTIONAL TO NOVEL Pt-BASED ANTINEOPLASTIC AGENTS: MECHANISTIC ASPECTS AND BIOLOGICAL EFFECTS 391
Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study 349
A Fluorescent Silver(I) Carbene Complex with Anticancer Properties: Synthesis, Characterization, and Biological Studies 347
A first-in-class and a fished out anticancer platinum compound:: Cis -[PtCl2(NH3)2] and cis -[PtI2(NH3)2] compared for their reactivity towards DNA model systems 345
Reactions of model proteins with aurothiomalate, a clinically established gold(I) drug: The comparison with auranofin 328
Iridium(I) Compounds as Prospective Anticancer Agents: Solution Chemistry, Antiproliferative Profiles and Protein Interactions for a Series of Iridium(I) N-Heterocyclic Carbene Complexes 325
Auranofin, Et3PAuCl, and Et3PAuI Are Highly Cytotoxic on Colorectal Cancer Cells: A Chemical and Biological Study 283
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer 262
PtI2(DACH), the iodido analogue of oxaliplatin as a candidate for colorectal cancer treatment: chemical and biological features 255
Auranofin and its Analogues Show Potent Antimicrobial Activity Covering Multiresistant Pathogens: Structure-Activity Relationships 239
The combined activation of K Ca 3.1 and inhibition of K v 11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells 227
Chlorido and bromido oxaliplatin analogues as potential agents for CRC treatment: Solution behavior, protein binding and cytotoxicity evaluation 207
Diruthenium Diacetate-Catalyzed Aerobic Oxidation of Hydroxylamines and Improved Chemoselectivity by Immobilization to Lysozyme 204
Gold(III) complexes with hydroxyquinoline, aminoquinoline and quinoline ligands: Synthesis, cytotoxicity, DNA and protein binding studies 203
Cisplatin and its dibromido analogue: a comparison of chemical and biological profiles 202
Elucidating the reactivity of Pt(II) complexes with (O,S) bidentate ligands towards DNA model systems 201
Structural and solution chemistry, antiproliferative effects, and serum albumin binding of three pseudohalide derivatives of auranofin 201
cis-Pt I2(NH3)2: a reappraisal 198
A case of extensive protein platination: The reaction of lysozyme with a Pt(ii)-terpyridine complex 198
Synthesis, characterization and DNA interactions of [Pt3(TPymT)Cl3], the trinuclear platinum(II) complex of the TPymT ligand 197
ESI-MS studies of the reactions of novel platinum(II) complexes containing O,O'-chelated acetylacetonate and sulfur ligands with selected model proteins 193
Arsenoplatin-1 Is a Dual Pharmacophore Anticancer Agent 192
Interactions of the organogold(III) compound Aubipyc with the copper chaperone Atox1: A joint mass spectrometry and circular dichroism investigation 183
Cytotoxic activity and protein binding through an unusual oxidative mechanism by an iridium(I)–NHC complex 182
Oxaliplatin vs. cisplatin: Competition experiments on their binding to lysozyme 182
Protein Metalation by Anticancer Metallodrugs: A Joint ESI MS and XRD Investigative Strategy 181
Reaction with proteins of a five-coordinate platinum(II) compound 181
Interaction of anticancer Ru(III) complexes with single stranded and duplex DNA model systems 180
Drug repositioning: auranofin as a prospective antimicrobial agent for the treatment of severe staphylococcal infections 169
Reactions of Cytotoxic Metallodrugs with Lysozyme in pure DMSO explored through UV-Vis Absorption Spectroscopy and ESI MS 159
Interaction of a gold(i) dicarbene anticancer drug with human telomeric DNA G-quadruplex: solution and computationally aided X-ray diffraction analysis 158
The cisplatin/serum albumin system: A reappraisal 157
Interplay of crystallography, Raman microspectroscopy and electrospray mass spectrometry for studying the reaction between ruthenium complexes and proteins 153
New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: synthesis and characterization, cytotoxicity and reactivity towards biomolecules 150
Synthesis and Mode of Action Studies on Iridium(I)–NHC Anticancer Drug Candidates 148
Ruthenium(II) 1,4,7-trithiacyclononane complexes of curcumin and bisdemethoxycurcumin: Synthesis, characterization, and biological activity 141
Interactions between Anticancertrans-Platinum Compounds and Proteins: Crystal Structures and ESI-MS Spectra of Two Protein Adducts oftrans-(Dimethylamino)(methylamino)dichloridoplatinum(II) 140
Mechanistic Insights Into the Anticancer Properties of the Auranofin Analog Au(PEt3)I: A Theoretical and Experimental Study 139
Platinum(II) Complexes with O,S Bidentate Ligands: Biophysical Characterization, Antiproliferative Activity, and Crystallographic Evidence of Protein Binding 137
Synthesis, DNA binding studies, and antiproliferative activity of novel Pt(II)-complexes with an L-alanyl-based ligand 136
The X-ray structure of the complex formed in the reaction between oxaliplatin and lysozyme 135
On the Different Mode of Action of Au(I)/Ag(I)-NHC Bis-Anthracenyl Complexes Towards Selected Target Biomolecules 134
Description of a Non-Canonical AsPt Blue Species Originating from the Aerobic Oxidation of AP-1 in Aqueous Solution 133
The first step of arsenoplatin-1 aggregation in solution unveiled by solving the crystal structure of its protein adduct 133
Reactions of Arsenoplatin-1 with Protein Targets: A Combined Experimental and Theoretical Study 132
Reactions of a tetranuclear Pt-thiosemicarbazone complex with model proteins 131
Reactions of cisplatin and cis-[PtI2(NH3)2] with molecular models of relevant protein sidechains: A comparative analysis 130
Peculiar Features in the Crystal Structure of the Adduct Formed betweencis-PtI2(NH3)2and Hen Egg White Lysozyme 129
Mechanistic studies on cytotoxic gold compounds 128
A Role for Metal-Based Drugs in Fighting COVID-19 Infection? The Case of Auranofin 123
In vitro anti-sars-cov-2 activity of selected metal compounds and potential molecular basis for their actions based on computational study 122
Interactions of carboplatin and oxaliplatin with proteins: Insights from X-ray structures and mass spectrometry studies of their ribonuclease A adducts 121
Unusual Structural Features in the Lysozyme Derivative of the Tetrakis(acetato)chloridodiruthenium(II,III) Complex 114
null 47
New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: synthesis and characterization, cytotoxicity and reactivity towards biomolecules 35
The impact of albumin conjugation on the cytotoxic properties of cisplatin, oxaliplatin and auranofin in cancer cells 32
null 31
Reactions of Arsenoplatin-1 with Protein Targets: A Combined Experimental and Theoretical Study (2022) Inorganic Chemistry 23
null 2
Totale 10.930
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.458
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.458
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022341 0 0 0 13 28 16 11 48 28 25 52 120
2022/20231.056 101 254 44 77 61 175 144 50 93 7 24 26
2023/2024412 16 32 64 10 21 91 24 95 9 19 13 18
2024/20252.533 86 275 155 380 804 428 34 77 57 56 104 77
2025/20263.341 279 362 175 290 306 116 344 126 264 201 522 356
2026/2027522 101 64 212 145 0 0 0 0 0 0 0 0
Totale 10.930